Kesimpta
Payments companies reported to CMS as associated with Kesimpta. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Kesimpta, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Kesimpta
These are the largest totals companies reported as associated with Kesimpta. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Barry Hendin | Phoenix, AZ | Neurology (Psychiatry & Neurology) | $58,382.64 |
| Joseph Habboushe | New York, NY | Emergency Medicine | $37,820.00 |
| Graham Walker | Stanford, CA | Emergency Medicine | $37,820.00 |
| Robert Shin | Charlottesville, VA | Neurology (Psychiatry & Neurology) | $31,102.02 |
| Shiv Saidha | Baltimore, MD | Neurology (Psychiatry & Neurology) | $26,331.72 |
| Clyde Markowitz | Philadelphia, PA | Neurology (Psychiatry & Neurology) | $24,680.39 |
| Thomas Leist | Philadelphia, PA | Neurology (Psychiatry & Neurology) | $23,734.22 |
| Sharon Stoll | New Haven, CT | Neurology (Psychiatry & Neurology) | $21,005.17 |
| Ann Bass | San Antonio, TX | Neurology (Psychiatry & Neurology) | $18,353.94 |
| Donald Negroski | Sarasota, FL | Neurology (Psychiatry & Neurology) | $17,927.99 |
Prescribed Kesimpta?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.